In addition, these agents have been found to inhibit the production of Tregs, TAMs, and MDSCs at tumor sites and to negatively regulate the expression of immunosuppressive cytokines such as TGF-β and IL-10 (30, 31). This evidence concerns the gene TGFB1 and neoplasm.